Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue
−0.69%
EPS
+19.3%
Free cash flow
+10.1%

Quarter to September 2026, against a year earlier

71.50 9.94 −12.21%
Market cap
$10.9B
P/E
19.5×
Fwd P/E
18.8×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a

Globus Medical, Inc. (GMED) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Globus Medical, Inc. (GMED) trades at a P/E ratio of 19.5×. Over the past ten years it has ranged from 16.9× (November 2016) to 246× (August 2024); the current reading is higher than 8% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 21.9× (80.11%)
FY2024 110× 144.79%
FY2023 45.1× 16.38%
FY2022 38.7× (20.65%)
FY2021 48.8× (22.21%)
FY2020 62.7× 68.28%
FY2019 37.3× 37.77%
FY2018 27.1× (29.82%)
FY2017 38.5× 67.92%
FY2016 23.0× (2.64%)

Quarterly newest first

Period P/E ratio Change
Sep 2026 18.1× (9.09%)
Jun 2026 19.9× 0.48%
Mar 2026 19.8× (9.71%)
Dec 2025 21.9× 19.51%
43 more quarters

Against its own ten years

Low 16.9× High 246×
Ten-year median 32.1×
Current reading's percentile 8

P/E ratio against peers

Company P/E ratio
BRKR Bruker Corporation compare n/m
GKOS Glaukos Corporation compare n/m
TXG 10x Genomics compare n/m
BIO Bio-Rad Laboratories, Inc. compare 9.7×
BIO.B Bio-Rad Laboratories, Inc. compare 9.9×
GMED Globus Medical, Inc. 19.5×
PODD Insulet Corporation compare 25.2×
SNN Smith & Nephew SNATS, Inc. compare 38.9×
PEN Penumbra, Inc. compare 80.3×
Medical Devices industry median 25.6×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on GMED